Insider Profile · SEC Form 4 Activity · Trailing 90 Days
Mazumdar Claire
Over the trailing 90 days, Mazumdar Claire (Director at Bicara Therapeutics Inc.) traded $680K of stock (net selling $490K) across 2 companies, per 9 SEC Form 4 transactions.
- Role
- Director
- Window
- Trailing 90 days · 9 transactions · CIK 2034671
- Net activity
- −$490K ($95K bought · $585K sold)
By Company (Trailing 90 Days)
Transactions (9)
| Date | Symbol | Type | Shares | Value | Description |
|---|---|---|---|---|---|
| 2026-07-10 | BCAX | Sell | 10.0K | $0 | Exercise or conversion of derivative security |
| 2026-07-10 | BCAX | Sell | 28 | $831 | Open market or private sale |
| 2026-07-10 | BCAX | Sell | 10.0K | $283K | Open market or private sale |
| 2026-07-10 | BCAX | Buy | 10.0K | $38K | Exercise or conversion of derivative security |
| 2026-06-09 | RLAY | Buy | 32.9K | $0 | Grant, award or other acquisition |
| 2026-05-18 | BCAX | Sell | 3.0K | $61K | Open market or private sale |
| 2026-05-18 | BCAX | Sell | 15.0K | $0 | Exercise or conversion of derivative security |
| 2026-05-18 | BCAX | Buy | 15.0K | $57K | Exercise or conversion of derivative security |
| 2026-05-18 | BCAX | Sell | 12.0K | $240K | Open market or private sale |
Activity shown covers the trailing 90 days of SEC Form 4 filings. "Buy" and "sell" follow the SEC acquired/disposed codes and include compensation events (grants, option exercises, tax withholding) unless noted. Historical fact, not investment advice.
Follow Mazumdar's next move
Real-time Form 4 alerts, insider track records, and cluster detection — matched to your watchlist.